Clearside Biomedical, Inc. Announces Appointment of Richard J. Croarkin to the Board of Directors
29 February 2016
Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye, today announced that Richard J. Croarkin has been appointed to Clearside’s Board of Directors. Mr. Croarkin is the former Senior Vice President of Finance, Chief Financial Officer & Corporate Strategy Officer of Alcon, Inc. and brings extensive global financial experience from working for diverse companies, including Nestlé Health Science S.A., Pepsico Incorporated and AMAX, Inc.
Drug manufacturing quality standards push on in India
29 February 2016
Foreign regulators and domestic producers in India are stepping into the breach to help the country improve its quality-control standards that have been the target in recent months of warning letters and outright bans for manufacturing shortfalls and in some cases fraud.
Intel hops on the precision medicine bandwagon with new projects for 2016
29 February 2016
Tech giant Intel ($INTC) is getting in on President Obama's Precision Medicine Initiative. The company is launching a new program to improve data analytics for genetic research, feeding into a swath of projects announced under the administration's latest precision medicine push.
China says to speed up approvals for some drugs
29 February 2016
China's drug regulator said it would accelerate approvals of new medicines, long a headache for pharmaceutical firms who complain it takes too long to get drugs to market. The China Food and Drug Administration (CFDA) said in a statement published on Friday that it would prioritize the approval of drugs with clear clinical value, including those that use advanced technology or innovative methods.
American Cancer Society, Samsung launch breast cancer pilot to integrate care, info and support
29 February 2016
The American Cancer Society has partnered with Samsung and software startup Breezie to conduct a pilot program to offer breast cancer patients a single point of contact across their medical team, family and caregivers as well as to offer access to customized treatment and clinical trial information and an online support group.
The top 20 drugs in 2020--worldwide sales
26 February 2016
Forecasting drug sales is a tricky business; just ask any biopharma CEO who has overpromised and underdelivered. The people who make it their business know that very well, and they update their numbers with every big shift in the market and every surprise result from a key clinical trial.
Drug Spending Slowed in 2015 After Discounts, CVS Health Says
26 February 2016
CVS Health Corp. said drug costs for its plans grew a modest 5 percent in 2015, far less than the 11.8 spending growth rate from a year before.
‘Extraordinary’ t-cell therapy results could change the face of cancer treatment
26 February 2016
Dr Stanley Riddell, an immunotherapy researcher and oncologist at Seattle’s Fred Hutchinson Cancer Research Centre, has presented ‘extraordinary’ results from adoptive T-cell strategies for cancer at the annual meeting of the American Association for the Advancement of Science (AAAS).
Will pharma advertisers pay the price for Google's pared-down search pages?
26 February 2016
Is Google's latest ad move going to cost pharma money? The tech giant says it's removing desktop search advertising on the right side of the page, often referred to as right rail ads. With ad inventory available only at the top or bottom of search pages, some advertising experts are worried about cost increases.
Top employers aim at Big Pharma with group project to bring down drug costs
25 February 2016
Skyrocketing drug prices have lawmakers, payers and the public up in arms. Now, a consortium of top employers is joining the fray with its own joint plans to bring down prices for expensive meds.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024